Learn More
OBJECTIVE We sought to assess the safety and therapeutic efficacy of autologous human bone marrow derived mononuclear cell transplantation on spinal cord injury in a phase I/II, nonrandomized, open-label study, conducted on 297 patients. MATERIALS AND METHODS We transplanted unmanipulated bone marrow mononuclear cells through a lumbar puncture, and(More)
  • 1